eFFECTOR Therapeutics, Inc.

EFTR · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$36-$23$16$14
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0-$1-$0
Stock-Based Comp.$5$5$9$0
Change in WC$2$3-$0-$1
Other Non-Cash-$0-$11-$49$0
Operating Cash Flow-$30-$26-$25$14
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$18$1$0
Inv. Purchases-$17-$52$0$0
Inv. Sales/Matur.$32$35$0$0
Other Inv. Act.$0-$18$0$0
Investing Cash Flow$14-$18$1-$0
Financing Activities
Debt Repay.$0$0$6-$2
Stock Issued$21$3$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0$53$0
Financing Cash Flow$21$3$59-$2
Forex Effect$0$0$0$0
Net Chg. in Cash$6-$41$34$12
Supplemental Information
Beg. Cash$9$50$15$3
End Cash$15$9$50$15
Free Cash Flow-$30-$26-$25$14
eFFECTOR Therapeutics, Inc. (EFTR) Financial Statements & Key Stats | AlphaPilot